Chiara Ciccarese

Circulating Tumor Cells in Patients with Recurrent or Metastatic Head and Neck Carcinoma: Prognostic and Predictive Significance

Salvatore Grisanti, Camillo Almici, Francesca Consoli et al. · PLoS ONE · 2014 · 83 citations · Full text

Medicine, Cell Biology, Oncology +17

Magnitude of PD-1, PD-L1 and T Lymphocyte Expression on Tissue from Castration-Resistant Prostate Adenocarcinoma: An Exploratory Analysis

Francesco Massari, Chiara Ciccarese, Anna Caliò et al. · Targeted Oncology · 2015 · 70 citations · Full text

Medicine, Immunology, Oncology +16

A multicenter phase 2 single arm study of cabozantinib in patients with advanced or unresectable renal cell carcinoma pre-treated with one immune-checkpoint inhibitor: The BREAKPOINT trial (Meet-Uro trial 03)

Giuseppe Procopio, Mélanie Claps, Chiara Pircher et al. · Tumori Journal · 2022 · 50 citations · Full text

Medicine, Oncology, Pharmacology +17

Cabozantinib After a Previous Immune Checkpoint Inhibitor in Metastatic Renal Cell Carcinoma: A Retrospective Multi-Institutional Analysis

Roberto Iacovelli, Chiara Ciccarese, Gaetano Facchini et al. · Targeted Oncology · 2020 · 39 citations · Full text

Medicine, Oncology, Pharmacology +12

Is Systemic Immune-Inflammation Index a Real Non-Invasive Biomarker to Predict Oncological Outcomes in Patients Eligible for Radical Cystectomy?

Pierluigi Russo, Filippo Marino, Francesco Rossi et al. · Medicina · 2023 · 39 citations · Full text

Medicine, Oncology, Surgery +17